-
Je něco špatně v tomto záznamu ?
Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
S. Schedin-Weiss, M. Inoue, L. Hromadkova, Y. Teranishi, NG. Yamamoto, B. Wiehager, N. Bogdanovic, B. Winblad, A. Sandebring-Matton, S. Frykman, LO. Tjernberg,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
BioMedCentral
od 2009-01-06
BioMedCentral Open Access
od 2009
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009 do 2020
ProQuest Central
od 2015-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Health & Medicine (ProQuest)
od 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
Springer Nature OA/Free Journals
od 2009-06-01
- MeSH
- Alzheimerova nemoc metabolismus patologie MeSH
- amyloidní beta-protein metabolismus MeSH
- axony metabolismus MeSH
- dendrity metabolismus MeSH
- krysa rodu rattus MeSH
- lidé středního věku MeSH
- lidé MeSH
- malá interferující RNA genetika metabolismus MeSH
- molekulární modely MeSH
- monoaminoxidasa genetika metabolismus MeSH
- mozek metabolismus patologie MeSH
- myši MeSH
- neurony metabolismus ultrastruktura MeSH
- presenilin-1 genetika MeSH
- receptory N-methyl-D-aspartátu metabolismus MeSH
- regulace genové exprese genetika MeSH
- sekretasy metabolismus MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- synapse metabolismus MeSH
- transfekce MeSH
- transformované buněčné linie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- myši MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Increased levels of the pathogenic amyloid β-peptide (Aβ), released from its precursor by the transmembrane protease γ-secretase, are found in Alzheimer disease (AD) brains. Interestingly, monoamine oxidase B (MAO-B) activity is also increased in AD brain, but its role in AD pathogenesis is not known. Recent neuroimaging studies have shown that the increased MAO-B expression in AD brain starts several years before the onset of the disease. Here, we show a potential connection between MAO-B, γ-secretase and Aβ in neurons. METHODS: MAO-B immunohistochemistry was performed on postmortem human brain. Affinity purification of γ-secretase followed by mass spectrometry was used for unbiased identification of γ-secretase-associated proteins. The association of MAO-B with γ-secretase was studied by coimmunoprecipitation from brain homogenate, and by in-situ proximity ligation assay (PLA) in neurons as well as mouse and human brain sections. The effect of MAO-B on Aβ production and Notch processing in cell cultures was analyzed by siRNA silencing or overexpression experiments followed by ELISA, western blot or FRET analysis. Methodology for measuring relative intraneuronal MAO-B and Aβ42 levels in single cells was developed by combining immunocytochemistry and confocal microscopy with quantitative image analysis. RESULTS: Immunohistochemistry revealed MAO-B staining in neurons in the frontal cortex, hippocampus CA1 and entorhinal cortex in postmortem human brain. Interestingly, the neuronal staining intensity was higher in AD brain than in control brain in these regions. Mass spectrometric data from affinity purified γ-secretase suggested that MAO-B is a γ-secretase-associated protein, which was confirmed by immunoprecipitation and PLA, and a neuronal location of the interaction was shown. Strikingly, intraneuronal Aβ42 levels correlated with MAO-B levels, and siRNA silencing of MAO-B resulted in significantly reduced levels of intraneuronal Aβ42. Furthermore, overexpression of MAO-B enhanced Aβ production. CONCLUSIONS: This study shows that MAO-B levels are increased not only in astrocytes but also in pyramidal neurons in AD brain. The study also suggests that MAO-B regulates Aβ production in neurons via γ-secretase and thereby provides a key to understanding the relationship between MAO-B and AD pathogenesis. Potentially, the γ-secretase/MAO-B association may be a target for reducing Aβ levels using protein-protein interaction breakers.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024770
- 003
- CZ-PrNML
- 005
- 20180712091901.0
- 007
- ta
- 008
- 180709s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13195-017-0279-1 $2 doi
- 035 __
- $a (PubMed)28764767
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Schedin-Weiss, Sophia $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden. sophia.schedin.weiss@ki.se.
- 245 10
- $a Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels / $c S. Schedin-Weiss, M. Inoue, L. Hromadkova, Y. Teranishi, NG. Yamamoto, B. Wiehager, N. Bogdanovic, B. Winblad, A. Sandebring-Matton, S. Frykman, LO. Tjernberg,
- 520 9_
- $a BACKGROUND: Increased levels of the pathogenic amyloid β-peptide (Aβ), released from its precursor by the transmembrane protease γ-secretase, are found in Alzheimer disease (AD) brains. Interestingly, monoamine oxidase B (MAO-B) activity is also increased in AD brain, but its role in AD pathogenesis is not known. Recent neuroimaging studies have shown that the increased MAO-B expression in AD brain starts several years before the onset of the disease. Here, we show a potential connection between MAO-B, γ-secretase and Aβ in neurons. METHODS: MAO-B immunohistochemistry was performed on postmortem human brain. Affinity purification of γ-secretase followed by mass spectrometry was used for unbiased identification of γ-secretase-associated proteins. The association of MAO-B with γ-secretase was studied by coimmunoprecipitation from brain homogenate, and by in-situ proximity ligation assay (PLA) in neurons as well as mouse and human brain sections. The effect of MAO-B on Aβ production and Notch processing in cell cultures was analyzed by siRNA silencing or overexpression experiments followed by ELISA, western blot or FRET analysis. Methodology for measuring relative intraneuronal MAO-B and Aβ42 levels in single cells was developed by combining immunocytochemistry and confocal microscopy with quantitative image analysis. RESULTS: Immunohistochemistry revealed MAO-B staining in neurons in the frontal cortex, hippocampus CA1 and entorhinal cortex in postmortem human brain. Interestingly, the neuronal staining intensity was higher in AD brain than in control brain in these regions. Mass spectrometric data from affinity purified γ-secretase suggested that MAO-B is a γ-secretase-associated protein, which was confirmed by immunoprecipitation and PLA, and a neuronal location of the interaction was shown. Strikingly, intraneuronal Aβ42 levels correlated with MAO-B levels, and siRNA silencing of MAO-B resulted in significantly reduced levels of intraneuronal Aβ42. Furthermore, overexpression of MAO-B enhanced Aβ production. CONCLUSIONS: This study shows that MAO-B levels are increased not only in astrocytes but also in pyramidal neurons in AD brain. The study also suggests that MAO-B regulates Aβ production in neurons via γ-secretase and thereby provides a key to understanding the relationship between MAO-B and AD pathogenesis. Potentially, the γ-secretase/MAO-B association may be a target for reducing Aβ levels using protein-protein interaction breakers.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a Alzheimerova nemoc $x metabolismus $x patologie $7 D000544
- 650 _2
- $a sekretasy $x metabolismus $7 D053829
- 650 _2
- $a amyloidní beta-protein $x metabolismus $7 D016229
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a axony $x metabolismus $7 D001369
- 650 _2
- $a mozek $x metabolismus $x patologie $7 D001921
- 650 _2
- $a transformované buněčné linie $7 D002461
- 650 _2
- $a dendrity $x metabolismus $7 D003712
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a regulace genové exprese $x genetika $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a monoaminoxidasa $x genetika $x metabolismus $7 D008995
- 650 _2
- $a neurony $x metabolismus $x ultrastruktura $7 D009474
- 650 _2
- $a presenilin-1 $x genetika $7 D053764
- 650 _2
- $a malá interferující RNA $x genetika $x metabolismus $7 D034741
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a receptory N-methyl-D-aspartátu $x metabolismus $7 D016194
- 650 _2
- $a synapse $x metabolismus $7 D013569
- 650 _2
- $a transfekce $7 D014162
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Inoue, Mitsuhiro $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden. Present address: Dainippon Sumitomo Pharma Co., Ltd, Drug Development Research Laboratories, Osaka, Japan.
- 700 1_
- $a Hromadkova, Lenka $u National Institute of Mental Health, Klecany, Czech Republic. Faculty of Science, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Teranishi, Yasuhiro $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden. Present address: Dainippon Sumitomo Pharma Co., Ltd, Drug Development Research Laboratories, Osaka, Japan.
- 700 1_
- $a Yamamoto, Natsuko Goto $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden. Present address: Dainippon Sumitomo Pharma Co., Ltd, Drug Development Research Laboratories, Osaka, Japan.
- 700 1_
- $a Wiehager, Birgitta $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden.
- 700 1_
- $a Bogdanovic, Nenad $u Department of Geriatric Medicine, University in Oslo, Memory Clinic, Oslo University Hospital, Oslo, Norway.
- 700 1_
- $a Winblad, Bengt $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden.
- 700 1_
- $a Sandebring-Matton, Anna $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden.
- 700 1_
- $a Frykman, Susanne $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden.
- 700 1_
- $a Tjernberg, Lars O $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden.
- 773 0_
- $w MED00172451 $t Alzheimer's research & therapy $x 1758-9193 $g Roč. 9, č. 1 (2017), s. 57
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28764767 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180712092154 $b ABA008
- 999 __
- $a ok $b bmc $g 1316901 $s 1021691
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 9 $c 1 $d 57 $e 20170801 $i 1758-9193 $m Alzheimer's research & therapy $n Alzheimers Res Ther $x MED00172451
- LZP __
- $a Pubmed-20180709